BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  NeuroMetrix Reports Q4 and Full Year 2022 Financial Results

  NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and full year ended December 31, 2022.

  February 23, 2023

   · 

  6 min read
• Business

  Calliditas - Year-End Report, 2022

  2022 was a fantastic year for Calliditas as we launched TARPEYO® in the US, the first approved drug for IgA nephropathy and a medication with the potential to be disease modifying based on the early stabilization of eGFR in patients at risk of rapid disease progression.

  February 23, 2023

   · 

  9 min read
• Pharm Country

  AtlantiCare First in Northeast to Deploy Optellum AI Alongside Robotics for Early Lung Cancer Diagnosis and Treatment

  AtlantiCare is the first healthcare system in the northeastern U.S. to use Optellum’s Virtual Nodule Clinic.

  February 23, 2023

   · 

  5 min read
• Business

  SphingoTec Appoints Dr. Florian Uhle as Medical Director

  Diagnostic company SphingoTec is pleased to announce the appointment of Dr. Florian Uhle as the company’s new Medical Director.

  February 23, 2023

   · 

  2 min read
• BioMidwest

  AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need

  AbbVie and Capsida Biotherapeutics Inc. announced an expanded strategic collaboration to develop genetic medicines for eye diseases with high unmet need.

  February 23, 2023

   · 

  4 min read
• Business

  Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results

  Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the fourth quarter and fiscal year ended December 31, 2022.

  February 23, 2023

   · 

  8 min read
• Deals

  Teleflex Announces Quarterly Dividend - February 23, 2023

  Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.

  February 23, 2023

   · 

  1 min read